Sustainability has been part of Valneva since the Group joined the United Nations Global Compact a decade ago. Valneva’s sustainability strategy “Reaching Further Where Most Needed” aims to amplify and expand the company’s positive impact on global health.
At Valneva, we have translated the core elements of this strategy into three pillars aligned with our purpose and mission: Protecting lives, Preserving the Planet, Reaching People.
At Valneva, we’re on a journey towards a better world, one where nobody dies or suffers from vaccine-preventable diseases. We develop and produce accessible vaccines to improve the lives of people who need them most.
Our sustainability strategy drives us further on this journey, while remaining true to our core vision and values.
Our Three Pillars for Sustainable Business
Leben schützen
We act to improve global public health through innovative vaccine development. By focusing on diseases with significant unmet medical needs and partnering with key public health organizations, Valneva works to ensure that life-saving vaccines are developed, made accessible to underserved populations, and maintained to the highest levels of safety and quality. 2 of our 3 commercial products are recognized as essential medicine by the World Health Organization, highlighting its critical importance in public health.
-
- Research & Development for Unmet Medical Needs
At Valneva, we focus our R&D on diseases with high unmet medical needs and significant global health risks. Our licensed vaccines and our pipeline of candidates are designed to address pathogens recognized as priority threats, including chikungunya, Lyme disease, and Shigella. - Universal & Affordable Access
Valneva is actively working to expand access to our vaccines in low- and middle-income countries (LMICs), using pricing strategies, policy frameworks, and partnerships to reduce barriers and ensure that communities with the highest need are not left behind. We strive to maintain pricing that is consistent, fair, and aligned with both regulatory requirements and the realities of healthcare delivery in LMICs. - Vaccine Safety
From early-stage clinical research to real-world post-marketing surveillance, Valneva follows the highest standards of vaccine safety. Our work is governed by a dedicated Pharmacovigilance and Medical Information Policy, which defines rigorous standards for monitoring of adverse events and transparent communication with healthcare professionals and organizations.
- Research & Development for Unmet Medical Needs
Den Planeten schützen
We recognize the importance of reducing the ways in which our business contributes to climate change and prioritizing the use of renewable, recyclable, and reusable resources. By embedding sustainability into our culture and strategy, Valneva seeks to address climate risks.
-
- Transition to a Lower Carbon Business Model
In 2025, we reduced our Scope 1 and Scope 2 emissions by 48% (market-based approach) compared to 2022, advancing towards our 2030 target of reducing emissions by 50Currently, we aim to actively manage our environmental footprint, for example by prioritizing the use of electricity from renewable sources across manufacturing and R&D sites, and assessing measures to reduce emissions from the value chain. - Reducing our Environmental Impact
We strive to reduce waste and use resources responsibly across our operations. By improving our understanding of the environmental impacts of our processes, we can make more informed choices throughout the product lifecycle. - Product Stewardship
At Valneva, we are working to integrate environmental considerations into every step of the vaccine lifecycle. This includes reducing packaging waste, selecting more sustainable and recyclable materials, and designing products with their end-of-life impact in mind. To deepen our understanding and improve performance, we track key environmental attributes of each product.
- Transition to a Lower Carbon Business Model
Menschen erreichen
People are central to Valneva’s mission to protect lives. We foster an inclusive and supportive workplace that promotes employee development, well-being and engagement, while upholding the highest standards of ethics, human rights and scientific integrity across our operations. In 2025, on average each employee completed 50 hours of training.
-
- Employee Engagement
Our people our future. We strive to create an inclusive, engaging and supportive workplace where employees can contribute their perspectives and make a meaningful impact through their work.French companies of a certain size must publish their GEI, which is a standard based on defined criteria to assess any inequalities. In 2025, we scored 96/100, placing the Company among the best performing French companies when it comes to Gender Equality. - Talent Management
Valneva is committed to supporting employee development throughout their journey. To support individual growth, we offer diverse training formats and fair compensation. We commit to providing a safe and respectful workplace for all, with zero tolerance for discrimination or misconduct. - Committed to Ethics
Valneva upholds the highest standards of ethics, transparency, and compliance. We are firmly committed to human rights, and ethical research is central to our mission and our activities, including clinical trials management. We prioritize patient safety and scientific rigor across all clinical trials sponsored or conducted by Valneva across all stages of clinical development.
- Employee Engagement
Unsere Berichte
Nachhaltigkeitsbericht 2025 (Englisch)Nachhaltigkeitsbericht 2025 – Zusammenfassung (Englisch)
Erklärung zu moderner Sklaverei und Zwangsarbeit 2025 (Englisch)
Access frühere berichte oder lesen Sie mehr über Corporate Compliance und Ethik at Valneva.
For questions related to Valneva’s sustainability performance and goals, please contact: sustainability@valneva.com
Our ESG Ratings & Recognition

Valneva is proud to be recognized with ISS ESG Prime Status, placing the company among the sustainability leaders in the biotechnology sector. This designation reflects strong ESG performance and Valneva’s commitment to responsible business practices.
Morningstar’s sustainability assessment also provides an independent view of how effectively we identify, manage and address sustainability-related risks hier .
Stiftungen und Mitgliedschaften
The United Nations Global Compact
Im Einklang mit seiner CSR-Strategie unterstützt Valneva den United Nations Global Compact und bezieht die zehn Prinzipien des UNGC in seine Strategien, Richtlinien und Verfahren ein.
Encephalitis International
Valneva unterstützt die Non-Profit Organisation Encephalitis International, die eine Welt ohne Tod und Behinderung durch Enzephalitis anstrebt. Ihre Aufgabe ist es, die Zukunft auf der ganzen Welt neu zu gestalten, indem sie Leben rettet, das Bewusstsein schärft und die Forschung vorantreibt.
Kommunales Engagement
Valneva unterstützt auch das soziale Engagement auf lokaler Ebene. Valneva glaubt an die Bedeutung von sozialem Engagement und ermutigt seine Mitarbeiter, an Wohltätigkeitsveranstaltungen teilzunehmen und sich ehrenamtlich in ihren lokalen Gemeinden zu engagieren.
Valneva Standorte
Valneva hat Niederlassungen in Österreich, Schweden, dem Vereinigten Königreich, Frankreich, Kanada und den USA.
Österreich
Wien
VALNEVA Austria GmbHCampus Vienna Biocenter 3
1030 Wien, Österreich T: +43 1 20620 F: +43 1 20 620 800 Kontaktieren Sie uns
Kanada
Montreal
Commercial Operations3535 Saint-Charles Blvd.,
Suite 600
Kirkland, Québec H9H 5B9
Kanada T: +1 514 630 6999 F: +1 514 630 9666 Kontaktieren Sie uns
Frankreich
Lyon
Ilot Saint-JosephBureaux Convergence Bâtiment A
12 ter quai Perrache
69002 Lyon, France T: +33 4 78 76 61 01 F: +33 4 43 86 63 30 Kontaktieren Sie uns
Nantes
6 rue Alain Bombard44800 Saint-Herblain
Frankreich T: +33 22 807 37 10 F: +33 2 28 07 37 11
Schweden
Solna
VALNEVA Sweden ABSE – 105 21 Stockholm, Sweden
Visiting Address:
Gunnar Asplunds allé 16
171 69 Solna, Sweden T: +46 (0)8 121 015 00
U.K.
Livingston
Valneva Scotland Ltd.Oakbank Park Road
Livingston EH53 0TG
Scotland T: +44 1506 446 600 F: +44 1506 446 601 Kontaktieren Sie uns
Fleet
Valneva UK LtdSentinel House
Ancells Business Park, Harvest Crescent
Fleet, GU51 2UZ
Vereinigtes Königreich T: +44 1252 704515
U.S.A.
Bethesda
Valneva USA, Inc.4550 Montgomery Ave., Suite 460
Bethesda, MD 20814, USA T: +1 301 556 4500 Kontaktieren Sie uns